Neoplasms: all 9,616 studies

Page 32 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.

• Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaCompletedNCT02484443Phase 2Results posted
• Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid TumorsTerminatedNCT02472977Phase 1/2Results posted
• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of DosesCompletedNCT02467270Phase 2Results posted
• Ceritinib Rare Indications Study in ALK+ TumorsTerminatedNCT02465528Phase 2Results posted
• Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.CompletedNCT02460224Phase 1/2Results posted
• Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell MalignanciesTerminatedNCT02457598Phase 1Results posted
• Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell MalignanciesCompletedNCT02457559Phase 1Results posted
• Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid TumorsCompletedNCT02454972Phase 2Results posted
• Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCTActive, not recruitingNCT02452697Phase 2Results posted
• Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid TumorsCompletedNCT02451007Phase 2Results posted
• A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid TumorsTerminatedNCT02444793Phase 1Results posted
• Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine TumorsCompletedNCT02441062Phase 2Results posted
• Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833CompletedNCT02437227Phase 1Results posted
• Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With OsteosarcomaCompletedNCT02432274Phase 1/2Results posted
• An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesTerminatedNCT02431260Phase 1/2Results posted
• The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.CompletedNCT02430311Phase 1Results posted
• Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid TumorsCompletedNCT02426892Phase 2Results posted
• COcoa Supplement and Multivitamin Outcomes StudyCompletedNCT02422745Phase 4Results posted
• Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut OriginCompletedNCT02420691Phase 2Results posted
• AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant AscitesTerminatedNCT02417753Phase 2Results posted
• A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic MalignanciesCompletedNCT02412722Phase 1Results posted
• Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)TerminatedNCT02410551Phase 2Results posted
• An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine NeoplasmsCompletedNCT02400996Results posted
• Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsCompletedNCT02399215Phase 2Results posted
• Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT02396134Phase 2Results posted
• Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)CompletedNCT02393859Phase 3Results posted
• QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With RituximabTerminatedNCT02384954Phase 1/2Results posted
• Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid TumorsTerminatedNCT02380677Phase 1/2Results posted
• Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic CancerTerminatedNCT02376933Not applicableResults posted
• Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)CompletedNCT02371369Phase 3Results posted
• Evaluating Cancer Survivorship Care ModelsCompletedNCT02362750Results posted
• Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139CompletedNCT02362464Phase 2Results posted
• Patient-Centered Care for the Older Adult With Hematologic MalignancyCompletedNCT02359838Not applicableResults posted
• High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With CancerStatus unknownNCT02357134Phase 2Results posted
• Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing SurgeryCompletedNCT02356471Not applicableResults posted
• Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)CompletedNCT02354534Phase 1Results posted
• A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic MalignanciesTerminatedNCT02354417Phase 1Results posted
• Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 MutationsCompletedNCT02352844Phase 2Results posted
• Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II StudyTerminatedNCT02345460Phase 2Results posted
• Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid MalignanciesCompletedNCT02343120Phase 1/2Results posted
• Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous SystemCompletedNCT02343081Phase 4Results posted
• Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid TumoursCompletedNCT02341456Phase 1Results posted
• Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic MalignanciesCompletedNCT02340728Phase 3Results posted
• A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesCompletedNCT02327169Phase 1Results posted
• FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB ExpressionCompletedNCT02325739Phase 1/2Results posted
• Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasCompletedNCT02323880Phase 1Results posted
• End-of-Life Care for African AmericansCompletedNCT02320123Not applicableResults posted
• Pembrolizumab and Monoclonal Antibody Therapy in Advanced CancerTerminatedNCT02318901Phase 1/2Results posted
• Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.CompletedNCT02315768Phase 1/2Results posted
• Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive SurgeryTerminatedNCT02315625Phase 2Results posted
• Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566CompletedNCT02315066Phase 1Results posted
• Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related MalignanciesCompletedNCT02308241Not applicableResults posted
• Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV MelanomaCompletedNCT02306850Phase 2Results posted
• Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or SarcomasCompletedNCT02304458Phase 1/2Results posted
• RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic CancersCompletedNCT02303990Phase 1Results posted
• De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up StudyCompletedNCT02281955Phase 2Results posted
• Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid TumorsCompletedNCT02281409Phase 1/2Results posted
• First in Human Study of M4344 in Participants With Advanced Solid TumorsCompletedNCT02278250Phase 1Results posted
• Prone Partial Breast Irradiation (PBI): a Prospective Randomized TrialActive, not recruitingNCT02276885Not applicableResults posted
• Phase 1 Study of E7090 in Subjects With Solid TumorCompletedNCT02275910Phase 1Results posted
• Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.CompletedNCT02272998Phase 2Results posted
• A Study of LY3022855 In Participants With Breast or Prostate CancerCompletedNCT02265536Phase 1Results posted
• An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced MalignanciesTerminatedNCT02265510Phase 1/2Results posted
• Icotinib for Completed Resected IB NSCLC With EGFR MutationCompletedNCT02264210Phase 2Results posted
• A Phase I Study of TAS-102 in Solid TumorsCompletedNCT02261532Phase 1Results posted
• ONO-4538 Phase I Study in Patients With Solid TumorCompletedNCT02261285Phase 1Results posted
• Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsCompletedNCT02259725Phase 2Results posted
• Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior TransplantationTerminatedNCT02259348Phase 2Results posted
• Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid LeukemiaCompletedNCT02257138Phase 1/2Results posted
• Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsTerminatedNCT02255461Phase 1Results posted
• Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic CancerCompletedNCT02243358Phase 2Results posted
• HCQ on PAR-4 Levels in Patients With Resectable Solid TumorsCompletedNCT02232243Phase 1Results posted
• Adjuvant HIPEC in High Risk Colon CancerCompletedNCT02231086Phase 3Results posted
• Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid MalignanciesTerminatedNCT02224599Phase 1/2Results posted
• A Study Of PF-06647020 For Adult Patients With Advanced Solid TumorsCompletedNCT02222922Phase 1Results posted
• A Study of LY3164530 in Participants With CancerCompletedNCT02221882Phase 1Results posted
• Proton Beam Re-Irradiation in Thoracic CancersCompletedNCT02204761Not applicableResults posted
• Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative RegimenTerminatedNCT02199041Phase 2Results posted
• Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid TumorsCompletedNCT02197572Phase 1Results posted
• Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLCCompletedNCT02197234Phase 1Results posted
• Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological MalignanciesCompletedNCT02193958Phase 1/2Results posted
• IDH1 Peptide Vaccine for Recurrent Grade II GliomaCompletedNCT02193347Phase 1Results posted
• A Safety and Tolerability of Circumferential Anal Canal Radiofrequency Ablation For Anal Intraepithelial NeoplasiaCompletedNCT02189161Not applicableResults posted
• Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast CancerCompletedNCT02187991Phase 2Results posted
• LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)CompletedNCT02187783Phase 2Results posted
• Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE)TerminatedNCT02186821Phase 2Results posted
• A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal CancerCompletedNCT02182804Not applicableResults posted
• A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036)CompletedNCT02179918Phase 1Results posted
• 18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain TumorsCompletedNCT02167204Not applicableResults posted
• Olfactory Function Following Endoscopic Endonasal Skull Base SurgeryTerminatedNCT02165969Results posted
• BGJ398 for Patients With Tumors With FGFR Genetic AlterationsTerminatedNCT02160041Phase 2Results posted
• A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative MalignanciesCompletedNCT02158858Phase 1/2Results posted
• Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic NeoplasmsCompletedNCT02158039Phase 1Results posted
• Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)CompletedNCT02157883Phase 1Results posted
• Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast CancerTerminatedNCT02154529Phase 1/2Results posted
• Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical ProstatectomyCompletedNCT02153918Phase 2Results posted
• αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface MalignanciesCompletedNCT02151448Phase 1/2Results posted
• Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic MalignanciesCompletedNCT02145403Phase 1/2Results posted
• Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic MalignancyCompletedNCT02139280Phase 2Results posted
• BI 836845 in Estrogen Receptor Positive Metastatic Breast CancerCompletedNCT02123823Phase 1Results posted

← Neoplasms overview